| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Lady Davis Research Institute of the Jewish General Hospital, Departments of Surgery (T.M.A., G.B.B.) and Medicine (H.H.), McGill University, Montréal, Québec, Canada H3T 1E2
Address all correspondence and requests for reprints to: Hung Huynh, Lady Davis Research Institute, McGill University, 3755 Cote Ste Catherine Road, Montréal, Québec, Canada H3T 1E2. E-mail: hhuynh{at}ldi.jgh.mcgill.ca
Erectile dysfunction is commonly experienced in men with diabetes mellitus. We report that the intracavernous pressure (ICP) rise in diabetic rats was 55% of the control and returned to normal following insulin (I) or insulin plus free oxygen scavenger (I + S) treatment. Insulin-like growth factor (IGF) binding protein (IGFBP) -3, -4, and -5 messenger RNA (mRNA) levels in the major pelvic ganglia (MPG) of diabetic rats were elevated by 2-fold, 2.6-fold, and 2.5-fold, respectively. Both I and I + S returned IGFBP-4 and 5 mRNA levels to normal, whereas IGFBP-3 gene expression was severely inhibited. IGFBP-2 gene expression was greatly inhibited by diabetes and was unresponsive to treatment. In the penis of diabetic rats, IGFBP-2 and -4 mRNA levels were low, whereas IGFBP-3 mRNA levels were elevated 10-fold. These effects were reversed by I and I + S. I and I + S also corrected the IGFBP-3 expression pattern. IGF-I gene expression in the penis and MPG was not significantly increased (P < 0.05) by diabetes and returned to normal levels following I or I + S treatment. Because IGFs are potent regulatory factors in vascular tone, this newly described activity of insulin may play an important role in the improvement of erectile function seen clinically and in animal models.
This article has been cited by other articles:
![]() |
P. M. Yamada and K.-W. Lee Perspectives in mammalian IGFBP-3 biology: local vs. systemic action Am J Physiol Cell Physiol, May 1, 2009; 296(5): C954 - C976. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cellek, P. N. Anderson, and N. A. Foxwell Nitrergic Neurodegeneration in Cerebral Arteries of Streptozotocin-Induced Diabetic Rats: A New Insight into Diabetic Stroke Diabetes, January 1, 2005; 54(1): 212 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cellek, N. A. Foxwell, and S. Moncada Two Phases of Nitrergic Neuropathy in Streptozotocin-Induced Diabetic Rats Diabetes, September 1, 2003; 52(9): 2353 - 2362. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Karkanis, L. DeYoung, G. B. Brock, and S. M. Sims Ca2+-activated Cl- channels in corpus cavernosum smooth muscle: a novel mechanism for control of penile erection J Appl Physiol, January 1, 2003; 94(1): 301 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Escrig, R. Marin, P. Abreu, J. Luis Gonzalez-Mora, and M. Mas Changes in Mating Behavior, Erectile Function, and Nitric Oxide Levels in Penile Corpora Cavernosa in Streptozotocin-Diabetic Rats Biol Reprod, January 1, 2002; 66(1): 185 - 189. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |